hrp0082p3-d2-830 | Growth (1) | ESPE2014
Wilk Magdalena
, Wzorek Katarzyna
, Tobor Ewa
, Dejniak Barbara
, Wedrychowicz Anna
, Dolezal-Oltarzewska Katarzyna
, Zygmunt-Gorska Agata
, Starzyk Jerzy
Background: Prader–Willi syndrome (PWS) is a genetic disorder with hypothalamic–pituitary dysfunction, in which obesity, excess fat to lean body mass cause metabolic complications. For the purpose of these disorders normalization, PWS patients have been treated with recombinant human GH (rhGH). Long-term tolerance in PWS children treated with rhGH is not well known and the data are still required.Objective and hypotheses: To evaluate effects of...